← Eichor
Study identifier: NCT05184790 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

LEARN: Learning Environment for Artificial Intelligence in Radiotherapy New Technology

Condition: Arrhythmias, Cardiac · Breast Cancer · Prostatic Cancer  ·  Sponsor: University of Sydney

PhaseN/A
Planned participants300
Who can joinAll sexes, 18 Years to no upper limit
Healthy volunteersNo

About this study

This study will develop a whole-of-body markerless tracking method for measuring the motion of the tumour and surrounding organs during radiation therapy to enable real-time image guidance. Routinely acquired patient data will be used to improve the training, testing and accuracy of a whole-of-body markerless tracking method. When the markerless tracking method is sufficiently advanced, according to the PI of each of the data collection sites, the markerless tracking method will be run in parallel to, but not intervening with, patient treatments during data acquisition.

This description comes directly from the study's public registry record.

Talk to the study team

Shona Silvester  ·  +61 2 8627 1185  ·  shona.silvester@sydney.edu.au

Always discuss trial participation with your own doctor first.

Locations (4)

Royal North Shore HospitalSaint Leonards, New South Wales, AustraliaRecruiting
Princess Alexandra HospitalWoolloongabba, Queensland, AustraliaNot Yet Recruiting
Alfred HealthMelbourne, Victoria, AustraliaNot Yet Recruiting
Peter MacCallum Cancer CentreMelbourne, Victoria, AustraliaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05184790